ArticleCancer management and research2015

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study.

J Randolph Hecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.